480 related articles for article (PubMed ID: 6299087)
1. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
[TBL] [Abstract][Full Text] [Related]
2. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM
Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
[TBL] [Abstract][Full Text] [Related]
3. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
5. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
Gertz MA; Brown ML; Hauser MF; Kyle RA
Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
[TBL] [Abstract][Full Text] [Related]
6. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
[TBL] [Abstract][Full Text] [Related]
7. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.
Hongo M; Hirayama J; Fujii T; Yamada H; Okubo S; Kusama S; Ikeda S
Am Heart J; 1987 Mar; 113(3):654-62. PubMed ID: 3030086
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
Eriksson P; Backman C; Bjerle P; Eriksson A; Holm S; Olofsson BO
Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
[TBL] [Abstract][Full Text] [Related]
9. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?
Hartmann A; Frenkel J; Hopf R; Baum RP; Hör G; Schneider M; Kaltenbach M
Int J Card Imaging; 1990; 5(4):227-31. PubMed ID: 2172406
[TBL] [Abstract][Full Text] [Related]
10. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease.
Schiff S; Bateman T; Moffatt R; Davidson R; Berman D
Am Heart J; 1982 Apr; 103(4 Pt 1):562-3. PubMed ID: 6278907
[No Abstract] [Full Text] [Related]
12. [Technetium TC 99m pyrophosphate myocardial scintigraphy in amyloidosis. Correlations with Doppler echocardiography].
Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams A; Desgrez A; Blondeau M
Arch Mal Coeur Vaiss; 1993 Jul; 86(7):1009-15. PubMed ID: 8291935
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
[TBL] [Abstract][Full Text] [Related]
14. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.
Janssen S; Piers DA; van Rijswijk MH; Meijer S; Mandema E
Eur J Nucl Med; 1990; 16(8-10):663-70. PubMed ID: 2166666
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85 years and older.
Goldstein SA; Lindsay J; Chandeysson PL; Nolan NG
Am J Cardiol; 1989 Mar; 63(11):752-3. PubMed ID: 2538049
[No Abstract] [Full Text] [Related]
16. Myocardial technetium-99m-pyrophosphate scintigraphy and echocardiography in the diagnosis of cardiac amyloidosis.
Planinc D; Franceschi D; Zigman M; Jerić M; Pagon LJ; Mihatov S; Rudar M
Acta Cardiol; 1992; 47(4):391-401. PubMed ID: 1387996
[No Abstract] [Full Text] [Related]
17. Symptomatic cardiac amyloidosis in an American family.
Ruder MA; Alpert MA; Sanfelippo JF; Dix JD; Whiting RB
South Med J; 1984 Jul; 77(7):831-3. PubMed ID: 6330908
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m pyrophosphate single-photon emission computed tomography of the heart in familial amyloid polyneuropathy.
Karp K; Näslund U; Backman C; Eriksson P
Int J Cardiol; 1987 Mar; 14(3):365-9. PubMed ID: 3030945
[TBL] [Abstract][Full Text] [Related]
19. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis.
Falk RH; Lee VW; Rubinow A; Skinner M; Cohen AS
Am J Cardiol; 1984 Nov; 54(8):1150-1. PubMed ID: 6093493
[No Abstract] [Full Text] [Related]
20. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S
Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
